Literature DB >> 6025984

Spironolactone.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6025984      PMCID: PMC1841798     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  10 in total

1.  A DOUBLE-BLIND EVALUATION OF ANTIHYPERTENSIVE DRUGS.

Authors:  R F GRENFELL; A H BRIGGS; W C HOLLAND
Journal:  Angiology       Date:  1964-04       Impact factor: 3.619

2.  The role of potassium in the natriuretic response to a steroidal lactone (SC-9420).

Authors:  F F TAYLOR; W W FALOON
Journal:  J Clin Endocrinol Metab       Date:  1959-12       Impact factor: 5.958

3.  Clinical and metabolic effects of aldosterone antagonism.

Authors:  J D SLATER; A MOXHAM; R HURTER; J D NABARRO
Journal:  Lancet       Date:  1959-11-28       Impact factor: 79.321

4.  The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.

Authors:  D N KERR; A E READ; R M HASLAM; S SHERLOCK
Journal:  Lancet       Date:  1958-11-22       Impact factor: 79.321

5.  Aldosterone antagonists.

Authors:  G W LIDDLE
Journal:  AMA Arch Intern Med       Date:  1958-12

6.  Spironolactone in hypertensive patients. Oligemic and antihypertensive effects.

Authors:  A J GEORGOPOULOS; H DUSTAN; I H PAGE
Journal:  Arch Intern Med       Date:  1961-09

7.  Use of spironolactone and hydrochlorothiazide in treatment of oedema.

Authors:  R O FARRELLY; R N HOWIE; J D NORTH
Journal:  Br Med J       Date:  1960-07-30

8.  Aldosterone excretion in patients with cirrhosis of the liver.

Authors:  I DYRENFURTH; C H STACEY; J C BECK; E H VENNING
Journal:  Metabolism       Date:  1957-11       Impact factor: 8.694

9.  Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt.

Authors:  C M KAGAWA; J A CELLA; C G VAN ARMAN
Journal:  Science       Date:  1957-11-15       Impact factor: 47.728

10.  Treatment of hypertension with spironolactone. Double-blind study.

Authors:  R L Wolf; M Mendlowitz; J Roboz; G P Styan; P Kornfeld; A Weigl
Journal:  JAMA       Date:  1966-12-12       Impact factor: 56.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.